CVS HEALTH CORPORATION |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 57.52 USD | +2.25% |
|
+3.39% | -27.09% |
| 05:22pm | CVS Health Retail Division Launches Snacks Brand Well Market | MT |
| 05-14 | Transcript : CVS Health Corporation Presents at Bank of America Health Care Conference 2024, May-14-2024 07:20 AM |
| Sales 2024 * | 369B 29,117B | Sales 2025 * | 388B 30,623B | Capitalization | 70.63B 5,573B |
|---|---|---|---|---|---|
| Net income 2024 * | 7.66B 605B | Net income 2025 * | 8.92B 704B | EV / Sales 2024 * | 0.32 x |
| Net Debt 2024 * | 48.83B 3,853B | Net Debt 2025 * | 45.01B 3,552B | EV / Sales 2025 * | 0.3 x |
| P/E ratio 2024 * |
9.7
x | P/E ratio 2025 * |
8.28
x | Employees | 259,500 |
| Yield 2024 * |
4.73% | Yield 2025 * |
4.69% | Free-Float | 70.67% |
More Fundamentals
* Assessed data
More news
Latest transcript on CVS Health Corporation
More recommendations
More press releases
More news
| 1 day | +2.24% | ||
| 1 week | +3.39% | ||
| Current month | -14.98% | ||
| 1 month | -16.60% | ||
| 3 months | -25.33% | ||
| 6 months | -15.65% | ||
| Current year | -27.09% |
1 week
55.20
57.72
1 month
53.7070.21
Current year
53.7083.25
1 year
53.7083.25
3 years
53.70111.25
5 years
51.72111.25
10 years
51.72113.65
| Managers | Title | Age | Since |
|---|---|---|---|
Karen Lynch
CEO | Chief Executive Officer | 61 | 27/11/18 |
Thomas Cowhey
DFI | Director of Finance/CFO | 51 | 31/01/22 |
David Falkowski
CMP | Compliance Officer | - | 28/02/11 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Anne Finucane
BRD | Director/Board Member | 71 | 19/01/11 |
Fernando Aguirre
BRD | Director/Board Member | 66 | 27/11/18 |
Mary Schapiro
BRD | Director/Board Member | 68 | 09/05/17 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 3.92% | 17 M€ | +7.35% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 16/05/24 | 57.54 | +2.28% | 8 971 517 |
| 15/05/24 | 56.26 | +0.46% | 16,430,970 |
| 14/05/24 | 56 | -0.83% | 15,410,680 |
| 13/05/24 | 56.47 | +1.16% | 11,767,627 |
| 10/05/24 | 55.82 | +0.25% | 9,288,418 |
Delayed Quote Nyse, May 16, 2024 at 07:37 pm
More quotes
CVS Health Corporation is one of the leading American suppliers of health products and services. Net sales (including intragroup) break down by activity as follows:
- medical insurance plan management services (45.6%; Pharmacy Benefit Management): administrative management (reimbursement management, patient claim processing, etc.), drug distribution, decision-making information, sales of medical information management services, etc.;
- retail distribution (28.5%): sale of prescription pharmaceutical products, OTC products, beauty and cosmetics products. At the end of 2023, products are marketed primarily via a network of more than 9,000 outlets and via the Internet. In addition, the group offers healthcare services through more than 1,000 clinics (MinuteClinic®);
- medical benefits management (25.8%);
- other (0.1%).
Calendar
01:00pm
- Annual General Meeting
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
B-
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
28
Last Close Price
56.26
USD
Average target price
71.37
USD
Spread / Average Target
+26.86%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -27.09% | 70.63B | |
| +19.62% | 85.64B | |
| +4.65% | 27.05B | |
| -5.53% | 17.97B | |
| +1.60% | 17.58B | |
| +3.58% | 15.64B | |
| +7.72% | 13.55B | |
| +9.91% | 13.41B | |
| +73.13% | 13.18B | |
| +70.09% | 12.99B |
- Stock Market
- Equities
- CVS Stock
